Clinical evaluation begins for Diagen™ to take patients’ genomic profiles into account along the nephrology care pathway
TRAASER, an innovative startup specializing in medical genomics, announces the start of clinical evaluation for its Diagen™ solution as part of the SAGE project, laureate of Bpifrance’s Digital Innovation Competition organized for
France’s “Investments for the Future” program, to develop medical genomics for kidney diseases.
In collaboration with the Paris AP-HP public hospital, the project seeks to develop and validate TRAASER’s Diagn™ expert software, associated with large-scale genomic data analysis software by Biofacet, in a kidney disease diagnosis protocol based on DNA sequencing. Genomic analysis, anticipated by most nephrologists, will provide greater diagnostic detail in cases of idiopathic renal deficiency, thus helping to clarify diagnosis for over 30% of the cases that remain unresolved today.
Read the press release